Overview

Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment

Status:
RECRUITING
Trial end date:
2030-06-01
Target enrollment:
Participant gender:
Summary
This study is examining the effects of standard of care cancer treatment as well as a medication called Sildenafil, on the cancer associated fatigue, cognition and the gut microbiome.
Phase:
PHASE2
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Treatments:
Sildenafil Citrate